Novavax, Inc. (NVAX)
8.70
+0.45
(+5.45%)
USD |
NASDAQ |
Feb 09, 16:00
8.67
-0.03
(-0.34%)
After-Hours: 20:00
Novavax EPS Diluted (Quarterly) : -1.246 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| Moderna, Inc. | -0.5128 |
| Plus Therapeutics, Inc. | -0.0412 |
| INVO Fertility, Inc. | -6.137 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -202.38M |
| Revenue (Quarterly) | 70.44M |
| Total Expenses (Quarterly) | 272.82M |
| Enterprise Value | 891.17M |
| Gross Profit Margin (Quarterly) | 71.90% |
| Profit Margin (Quarterly) | -287.3% |
| Earnings Yield | 20.33% |
| Operating Earnings Yield | 28.28% |
| Normalized Earnings Yield | 27.15 |